Betamethasone - Mucositis - chemotherapy / radiotherapy induced

You are here : Home > Formulary Search > Betamethasone - Mucositis - chemotherapy / radiotherapy induced

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red

Formulations :

Soluble tablets

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

SPC

Restrictions / Comments :

Important

Patients on everolimus treatment. Used as a mouthwash, in line with St Luke's SACT protocols

Documentation

No records returned.

PAD Profile

ChemicalSubstance :

Betamethasone

Indication :

Mucositis - chemotherapy / radiotherapy induced

Group Name :

Keywords :

Oropharyngeal lesions, oral ulceration, oral inflammation

Brand Names Include :

Important Information :

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Supporting Documents :

Committee Recommendations (1)

05 Feb 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Betamethasone is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Mucositis - chemotherapy / radiotherapy induced.